Evonik announced Christian Kullmann will remain CEO until 2030, extending his tenure.
Michael Rauch appointed CFO effective May 1, 2026, bringing 16 years of finance and strategy experience from Henkel.
Rauch previously held senior roles at CompuGroup Medical and Douglas, and served as interim CEO of Selecta AG.
New CFO will focus on restoring investor confidence in capital allocation amid concerns over free cash flow and balance‑sheet flexibility.